CTIM-31. SAFETY AND TOLERABILITY OF OLAPARIB, TEMOZOLOMIDE, AND PEMBROLIZUMAB IN A PHASE 2 TRIAL IN PATIENTS WITH PROGRESSIVE GLIOBLASTOMA
CTIM-31. 奥拉帕尼、替莫唑胺和帕博利珠单抗在进展性胶质母细胞瘤患者中的 II 期试验的安全性和耐受性
期刊:Animals
影响因子:2.7
doi:10.3390/ani15243614
Kimram, Kanogwan; Suwanna, Nirut; Tiraphut, Bordin; Limsuwan, Sasithorn; Thongyuan, Suporn; Tansakul, Natthasit; Green, Julianne; Lovelace, Tamika; Flynn, Madelaine; Palavecino, Elizabeth; Bischoff, Werner; Cameron, David; Dao, Justine; Rubino, Christopher M; Menetrey, Annick; Cammarata, Anthony P; Hammel, Jeffrey P; Dieppois, Guennaelle; Nowakowska, Justyna; Bravo, Juan; VanScoy, Brian D; Hawser, Stephen; Nicolas-Metral, Valerie; Bhavnani, Sujata M; Castro, L Nicolas Gonzalez; McCluskey, Christine; Westergaard, Catharina; Fox, Rachel; Chukwueke, Ugonma; Youssef, Gilbert; Aquilanti, Elisa; Lee, Eudocia; Reardon, David; Arnaout, Omar; Bi, Wenya L; Peruzzi, Pierpaolo; Golby, Alexandra; Kim, Jiyoon; Vega, Rafael; Schaff, Lauren; Arrillaga-Romany, Isabel; Ligon, Keith; Prins, Robert; Wen, Patrick
